Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2012 2
2013 2
2014 2
2015 4
2016 6
2017 4
2018 4
2019 4
2020 9
2021 10
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells.
Dixit D, Prager BC, Gimple RC, Poh HX, Wang Y, Wu Q, Qiu Z, Kidwell RL, Kim LJY, Xie Q, Vitting-Seerup K, Bhargava S, Dong Z, Jiang L, Zhu Z, Hamerlik P, Jaffrey SR, Zhao JC, Wang X, Rich JN. Dixit D, et al. Among authors: hamerlik p. Cancer Discov. 2021 Feb;11(2):480-499. doi: 10.1158/2159-8290.CD-20-0331. Epub 2020 Oct 6. Cancer Discov. 2021. PMID: 33023892 Free PMC article.
Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression.
Wang X, Prager BC, Wu Q, Kim LJY, Gimple RC, Shi Y, Yang K, Morton AR, Zhou W, Zhu Z, Obara EAA, Miller TE, Song A, Lai S, Hubert CG, Jin X, Huang Z, Fang X, Dixit D, Tao W, Zhai K, Chen C, Dong Z, Zhang G, Dombrowski SM, Hamerlik P, Mack SC, Bao S, Rich JN. Wang X, et al. Among authors: hamerlik p. Cell Stem Cell. 2018 Apr 5;22(4):514-528.e5. doi: 10.1016/j.stem.2018.03.011. Cell Stem Cell. 2018. PMID: 29625067 Free PMC article.
Brain tumor vessels-a barrier for drug delivery.
Hempel C, Johnsen KB, Kostrikov S, Hamerlik P, Andresen TL. Hempel C, et al. Among authors: hamerlik p. Cancer Metastasis Rev. 2020 Sep;39(3):959-968. doi: 10.1007/s10555-020-09877-8. Cancer Metastasis Rev. 2020. PMID: 32488404 Review.
VEGF-C as a putative therapeutic target in cancer.
Michaelsen SR, Poulsen HS, Hamerlik P. Michaelsen SR, et al. Among authors: hamerlik p. Oncotarget. 2019 Jun 18;10(40):3988-3990. doi: 10.18632/oncotarget.27007. eCollection 2019 Jun 18. Oncotarget. 2019. PMID: 31258839 Free PMC article. No abstract available.
Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma.
Holst CB, Christensen IJ, Vitting-Seerup K, Skjøth-Rasmussen J, Hamerlik P, Poulsen HS, Johansen JS. Holst CB, et al. Among authors: hamerlik p. Neurooncol Adv. 2021 Jun 1;3(1):vdab072. doi: 10.1093/noajnl/vdab072. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34286278 Free PMC article.
A High-Affinity Peptide Ligand Targeting Syntenin Inhibits Glioblastoma.
Haugaard-Kedström LM, Clemmensen LS, Sereikaite V, Jin Z, Fernandes EFA, Wind B, Abalde-Gil F, Daberger J, Vistrup-Parry M, Aguilar-Morante D, Leblanc R, Egea-Jimenez AL, Albrigtsen M, Jensen KE, Jensen TMT, Ivarsson Y, Vincentelli R, Hamerlik P, Andersen JH, Zimmermann P, Lee W, Strømgaard K. Haugaard-Kedström LM, et al. Among authors: hamerlik p. J Med Chem. 2021 Feb 11;64(3):1423-1434. doi: 10.1021/acs.jmedchem.0c00382. Epub 2021 Jan 27. J Med Chem. 2021. PMID: 33502198
45 results